Eli Lilly Says It Will Cut the Price of Insulin

Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance

Eli Lilly and Company Announces 70% Reductions in Insulin Prices

Eli Lilly plans to slash some insulin prices, expand cost cap for diabetes patients

Unaffordable insulin may be a human rights abuse, watchdog says

Eli Lilly's weak diabetes drugs sales cloud 2023 profit forecast

Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetes

Eli Lilly's diabetes drug back to shelf after two-month shortage

Lilly’s Mounjaro receives FDA approval for type 2 diabetes treatment

Michigan attorney general files to investigate Lilly for insulin pricing under the state's consumer protection law